BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15352605)

  • 1. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Chan AA; Lau A; Pirzkall A; Chang SM; Verhey LJ; Larson D; McDermott MW; Dillon WP; Nelson SJ
    J Neurosurg; 2004 Sep; 101(3):467-75. PubMed ID: 15352605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
    Graves EE; Nelson SJ; Vigneron DB; Chin C; Verhey L; McDermott M; Larson D; Sneed PK; Chang S; Prados MD; Lamborn K; Dillon WP
    Neurosurgery; 2000 Feb; 46(2):319-26; discussion 326-8. PubMed ID: 10690720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
    Graves EE; Nelson SJ; Vigneron DB; Verhey L; McDermott M; Larson D; Chang S; Prados MD; Dillon WP
    AJNR Am J Neuroradiol; 2001 Apr; 22(4):613-24. PubMed ID: 11290467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study.
    Regine WF; Patchell RA; Strottmann JM; Meigooni A; Sanders M; Young B
    J Neurosurg; 2000 Dec; 93 Suppl 3():37-41. PubMed ID: 11143260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging.
    Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T
    J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation.
    Tamura K; Aoyagi M; Wakimoto H; Ando N; Nariai T; Yamamoto M; Ohno K
    J Neurosurg; 2010 Aug; 113(2):310-8. PubMed ID: 20205512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.
    Einstein DB; Wessels B; Bangert B; Fu P; Nelson AD; Cohen M; Sagar S; Lewin J; Sloan A; Zheng Y; Williams J; Colussi V; Vinkler R; Maciunas R
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):668-74. PubMed ID: 22445005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases.
    Chernov MF; Hayashi M; Izawa M; Usukura M; Yoshida S; Ono Y; Muragaki Y; Kubo O; Hori T; Takakura K
    Brain Tumor Pathol; 2006 Apr; 23(1):19-27. PubMed ID: 18095115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.
    Oh J; Henry RG; Pirzkall A; Lu Y; Li X; Catalaa I; Chang S; Dillon WP; Nelson SJ
    J Magn Reson Imaging; 2004 May; 19(5):546-54. PubMed ID: 15112303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note.
    Levivier M; Wikier D; Goldman S; David P; Metens T; Massager N; Gerosa M; Devriendt D; Desmedt F; Simon S; Van Houtte P; Brotchi J
    J Neurosurg; 2000 Dec; 93 Suppl 3():233-8. PubMed ID: 11143256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery.
    Chernov M; Hayashi M; Izawa M; Nakaya K; Ono Y; Usukura M; Yoshida S; Kato K; Muragaki Y; Nakamura R; Iseki H; Hori T; Takakura K
    Minim Invasive Neurosurg; 2007 Aug; 50(4):233-8. PubMed ID: 17948183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.
    Nelson SJ; Kadambi AK; Park I; Li Y; Crane J; Olson M; Molinaro A; Roy R; Butowski N; Cha S; Chang S
    Neuro Oncol; 2017 Mar; 19(3):430-439. PubMed ID: 27576874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas.
    Chuang CF; Chan AA; Larson D; Verhey LJ; McDermott M; Nelson SJ; Pirzkall A
    Technol Cancer Res Treat; 2007 Oct; 6(5):375-82. PubMed ID: 17877425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery.
    Truong MT; St Clair EG; Donahue BR; Rush SC; Miller DC; Formenti SC; Knopp EA; Han K; Golfinos JG
    Neurosurgery; 2006 Jul; 59(1):86-97; discussion 86-97. PubMed ID: 16823304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.